• Aceragen bags Enzyvant drug and $35M, plots fast path to market

    7 days ago - By Fierce Biotech

    Aceragen bags Enzyvant drug and $35M, plots fast path to market ntaylor
    Mon, 05/03/2021 - 07:56
    Read more ...

     

  • Avrobio plans head-to-head Fabrazyme trial after FDA changes path to market

    7 days ago - By Fierce Biotech

    Avrobio plans head-to-head Fabrazyme trial after FDA changes path to market ntaylor
    Mon, 05/03/2021 - 08:41
    Read more ...